Across TCGA pan-cancer cohorts, MIR5094 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR5094’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR5094 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR5094 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.
STAD and THCA are the cancer types where MIR5094 tumor–normal differential expression is most reproducible.